Literature DB >> 370681

Stereotaxic exploration in 200 supratentorial brain tumors. Its value in addition to computerized tomography.

J M Scarabin, J Pecker, J M Brucher, B Vallée, Y Guégan, J Faivre, J Simon.   

Abstract

The authors emphasize the advantages of stereotaxic methodology in the management of 200 brain tumors. Nowadays computerized tomography is the first stage of radiologic diagnosis. Both CT scan and stereotaxic examination have been carried out in more than 35% of these tumors. Rather than a comparison of the two examinations, the authors' purpose is to attempt to demonstrate their complementarity in the assessment of location, volume, and nature of the lesion and eventually in the choice of a therapeutic attitude. Analysis of topographic data and staged biopsies, gathered from the 'stereotaxic space,' provides the neurosurgeon with accurate information for planned surgical excision or interstitial irradiation.

Entities:  

Mesh:

Year:  1978        PMID: 370681     DOI: 10.1007/bf00395371

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  2 in total

1.  Stereotaxic computed tomography.

Authors:  M Bergström; T Greitz
Journal:  AJR Am J Roentgenol       Date:  1976-07       Impact factor: 3.959

2.  Stereotaxic exploration and biopsy of tumours in the region of the tentorial hiatus.

Authors:  J M Scarabin; J Pecker; B Vallée; G Guy; G Le Clech; J Simon
Journal:  J Neuroradiol       Date:  1978-03       Impact factor: 3.447

  2 in total
  3 in total

1.  Cerebral angiography under stereotactic conditions. Technical note.

Authors:  J R Moringlane; B Lippitz; C B Ostertag
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

2.  Applications of CT-adapted stereotaxis for the diagnosis and treatment of intracranial lesions.

Authors:  R D Lobato; J J Rivas
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

3.  Results of 200 intracranial stereotactic biopsies.

Authors:  P Grunert; K Ungersböck; J Bohl; K Kitz; N Hopf
Journal:  Neurosurg Rev       Date:  1994       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.